Article
Src mediates cigarette smoke-induced resistance to tyrosine kinase inhibitors in NSCLC cells.
Molecular cancer therapeutics - 1 Aug 2013
Filosto Simone, Baston David S, Chung Samuel, Becker Cathleen R, Goldkorn Tzipora
Abstract excerpt
The EGF receptor (EGFR) is a proto-oncogene commonly dysregulated in several cancers including non-small cell lung carcinoma (NSCLC) and, thus, is targeted for treatment using tyrosine kinase inhibitors (TKI) such as erlotinib. However, despite the efficacy observed in patients with NSCLC harboring oncogenic variants of the EGFR, general ineffectiveness of TKIs in patients with NSCLC who are current and former...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
